225 related articles for article (PubMed ID: 11091278)
41. Thymic atrophy in type 2 reovirus infected mice: immunosuppression and effects of thymic hormone. Thymic atrophy caused by reo-2.
Onodera T; Taniguchi T; Tsuda T; Yoshihara K; Shimizu S; Sato M; Awaya A; Hayashi T
Thymus; 1991 Sep; 18(2):95-109. PubMed ID: 1656552
[TBL] [Abstract][Full Text] [Related]
42. Modulation of dietary fat on the toxicological effects in thymus and spleen in BALB/c mice exposed to perfluorooctane sulfonate.
Wang Y; Wang L; Liang Y; Qiu W; Zhang J; Zhou Q; Jiang G
Toxicol Lett; 2011 Jul; 204(2-3):174-82. PubMed ID: 21571052
[TBL] [Abstract][Full Text] [Related]
43. In vitro steady-state levels of hydrogen peroxide after exposure of male F344 rats and female B6C3F1 mice to hepatic peroxisome proliferators.
Tomaszewski KE; Agarwal DK; Melnick RL
Carcinogenesis; 1986 Nov; 7(11):1871-6. PubMed ID: 3769136
[TBL] [Abstract][Full Text] [Related]
44. High-dose dietary exposure of mice to perfluorooctanoate or perfluorooctane sulfonate exerts toxic effects on myeloid and B-lymphoid cells in the bone marrow and these effects are partially dependent on reduced food consumption.
Qazi MR; Nelson BD; DePierre JW; Abedi-Valugerdi M
Food Chem Toxicol; 2012 Sep; 50(9):2955-63. PubMed ID: 22732150
[TBL] [Abstract][Full Text] [Related]
45. An increase in mouse tumor growth by an in vivo immunomodulating effect of titanium dioxide nanoparticles.
Moon EY; Yi GH; Kang JS; Lim JS; Kim HM; Pyo S
J Immunotoxicol; 2011; 8(1):56-67. PubMed ID: 21288165
[TBL] [Abstract][Full Text] [Related]
46. Epigenetic effects of the continuous exposure to peroxisome proliferator WY-14,643 in mouse liver are dependent upon peroxisome proliferator activated receptor alpha.
Pogribny IP; Tryndyak VP; Woods CG; Witt SE; Rusyn I
Mutat Res; 2007 Dec; 625(1-2):62-71. PubMed ID: 17586532
[TBL] [Abstract][Full Text] [Related]
47. Perfluorooctanoic acid (PFOA) exposure induces splenic atrophy via overactivation of macrophages in male mice.
Guo H; Zhang H; Sheng N; Wang J; Chen J; Dai J
J Hazard Mater; 2021 Apr; 407():124862. PubMed ID: 33360190
[TBL] [Abstract][Full Text] [Related]
48. Differential activation of hepatic NF-kappaB in rats and hamsters by the peroxisome proliferators Wy-14,643, gemfibrozil, and dibutyl phthalate.
Tharappel JC; Cunningham ML; Spear BT; Glauert HP
Toxicol Sci; 2001 Jul; 62(1):20-7. PubMed ID: 11399789
[TBL] [Abstract][Full Text] [Related]
49. Short-term administration of 17-beta estradiol to outbred male CD-1 mice induces changes in the immune system, but not in reproductive organs.
Karpuzoglu-Sahin E; Gogal RM; Hardy C; Sponenberg P; Ahmed SA
Immunol Invest; 2005; 34(1):1-26. PubMed ID: 15773569
[TBL] [Abstract][Full Text] [Related]
50. WY-14,643 induced cell proliferation and oxidative stress in mouse liver are independent of NADPH oxidase.
Woods CG; Burns AM; Bradford BU; Ross PK; Kosyk O; Swenberg JA; Cunningham ML; Rusyn I
Toxicol Sci; 2007 Aug; 98(2):366-74. PubMed ID: 17483499
[TBL] [Abstract][Full Text] [Related]
51. Specific changes in the protein composition of rat liver in response to the peroxisome proliferators ciprofibrate, Wy-14,643 and di-(2-ethylhexyl)phthalate.
Watanabe T; Lalwani ND; Reddy JK
Biochem J; 1985 May; 227(3):767-75. PubMed ID: 4004798
[TBL] [Abstract][Full Text] [Related]
52. Does developmental exposure to perflurooctanoic acid (PFOA) induce immunopathologies commonly observed in neurodevelopmental disorders?
Hu Q; Franklin JN; Bryan I; Morris E; Wood A; DeWitt JC
Neurotoxicology; 2012 Dec; 33(6):1491-1498. PubMed ID: 23137609
[TBL] [Abstract][Full Text] [Related]
53. Changes in spleen and thymus cell phenotypes in mice vaccinated with the Coxiella burnetii phase I whole-cell vaccine or the chloroform-methanol residue subunit vaccine.
Waag DM; Williams JC
Acta Virol; 1996 Apr; 40(2):87-94. PubMed ID: 8886117
[TBL] [Abstract][Full Text] [Related]
54. Effects of the rodent peroxisome proliferator and hepatocarcinogen, perfluorooctanoic acid, on apoptosis in human hepatoma HepG2 cells.
Shabalina IG; Panaretakis T; Bergstrand A; DePierre JW
Carcinogenesis; 1999 Dec; 20(12):2237-46. PubMed ID: 10590214
[TBL] [Abstract][Full Text] [Related]
55. Ability of peroxisome proliferators to induce cell transformation, chromosome aberrations and peroxisome proliferation in cultured Syrian hamster embryo cells.
Tsutsui T; Watanabe E; Barrett JC
Carcinogenesis; 1993 Apr; 14(4):611-8. PubMed ID: 8472324
[TBL] [Abstract][Full Text] [Related]
56. Differential effect of peroxisome proliferators on rat glutathione S-transferase isoenzymes.
Voskoboinik I; Drew R; Ahokas JT
Toxicol Lett; 1996 Oct; 87(2-3):147-55. PubMed ID: 8914623
[TBL] [Abstract][Full Text] [Related]
57. Flow cytometric and immunohistochemical evaluation of ethanol-induced changes in splenic and thymic lymphoid cell populations.
Saad AJ; Jerrells TR
Alcohol Clin Exp Res; 1991 Oct; 15(5):796-803. PubMed ID: 1755511
[TBL] [Abstract][Full Text] [Related]
58. Immunomodulation by diethylstilbestrol is dose and gender related: effects on thymocyte apoptosis and mitogen-induced proliferation.
Calemine JB; Gogal RM; Lengi A; Sponenberg P; Ahmed SA
Toxicology; 2002 Sep; 178(2):101-18. PubMed ID: 12160618
[TBL] [Abstract][Full Text] [Related]
59. Chronic peroxisome proliferation and hepatomegaly associated with the hepatocellular tumorigenesis of di(2-ethylhexyl)phthalate and the effects of recovery.
David RM; Moore MR; Cifone MA; Finney DC; Guest D
Toxicol Sci; 1999 Aug; 50(2):195-205. PubMed ID: 10478855
[TBL] [Abstract][Full Text] [Related]
60. Toxicogenomic dissection of the perfluorooctanoic acid transcript profile in mouse liver: evidence for the involvement of nuclear receptors PPAR alpha and CAR.
Rosen MB; Lee JS; Ren H; Vallanat B; Liu J; Waalkes MP; Abbott BD; Lau C; Corton JC
Toxicol Sci; 2008 May; 103(1):46-56. PubMed ID: 18281256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
